购物车
- 全部删除
- 您的购物车当前为空
GSK319347A 是一种具有选择性和有效性的 TBK1 和 IKKε 的双重抑制剂,具有潜在的抗肿瘤活性,对 IKK2 活性 有抑制作用,可用于研究膀胱癌和肺腺癌。
为众多的药物研发团队赋能,
让新药发现更简单!
GSK319347A 是一种具有选择性和有效性的 TBK1 和 IKKε 的双重抑制剂,具有潜在的抗肿瘤活性,对 IKK2 活性 有抑制作用,可用于研究膀胱癌和肺腺癌。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,060 | 现货 | |
5 mg | ¥ 2,660 | 现货 | |
10 mg | ¥ 4,260 | 现货 | |
25 mg | ¥ 6,650 | 现货 | |
50 mg | ¥ 8,960 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 2,750 | 现货 |
产品描述 | GSK319347A is a selective and potent dual inhibitor of TBK1 and IKKε with potential anti-tumor activity and inhibition of IKK2 activity, which can be used in the study of bladder cancer and lung adenocarcinoma. |
靶点活性 | IKKε:469 nM, TBK1:93 nM, IKK2:790 nM |
体外活性 | GSK319347A (Compound 1) inhibits the TBK1 enzyme with an IC50 of 93 nM, demonstrating good cell potency at 72 nM. Additionally, IKK-3 Inhibitor shows excellent selectivity against cell-cycle kinases CDK2 and AurB[1]. IKK-3 Inhibitor (Compound 13) is a novel IκB kinase 2 (IKK2) inhibitor with an IC50 of 790 nM[1]. |
分子量 | 469.53 |
分子式 | C22H19N3O5S2 |
CAS No. | 862812-98-4 |
Smiles | COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(s3)C#N)c2cc1OC |
密度 | 1.39 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 40 mg/mL (85.19 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容